|
|
Michelle Butler's practice focuses on pharmaceutical, device, and healthcare law, including civil litigation, and related matters involving the Federal Trade Commission and the Consumer Product Safety Commission. In the pharmaceutical and biologics areas, Michelle has expertise in areas including combination products, orphan drugs, and 505(b)(2)s. She regularly counsels pharmaceutical and device companies on compliance issues and matters pertaining to government contracts. Michelle joined the firm in 1998 after graduating from the Georgetown University Law Center where she served on the staff of The Tax Lawyer. Michelle is admitted to practice law in the District of Columbia and Maryland and before the U.S. District Court for the District of Columbia. She received a Bachelor of Arts in Human Biology from Stanford University in 1995.
Developments in the Law
|
